From the Editor-in-Chief
Patients should have access to this vital and emerging medical specialty.
by William G. Nelson, MD, PhD
Inside Inflammation | Weighing Tumor Testing | Making Treatment Decisions | Advances in Treating Non–Small Cell Lung Cancer | Inside the 21st Century Cures Act | Cancer Cells Can Change as They Grow and Spread | Map Stories
Your Cancer Guide
Determining what to tell people about your cancer requires careful thought.
by Hester Hill Schnipper
Caregiving With Confidence
When cancer becomes a chronic condition, caregiving requires adjusting to a new normal.
by Aimee Swartz
An acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.
by Jennifer Walker
Scientists are working to understand the molecular processes that transform normal cells into cancer cells in the hope they can prevent the disease before it starts.
by Marci A. Landsmann
Another perspective on your disease may help you find the best cancer care.
by Stephen Ornes
Yesterday & Today
Michael Landon, best known for his roles on Little House on the Prairie and Bonanza, created and starred in programs that portrayed family values with authenticity and humor.
Tanning Trouble | Movement for Health
Princess Dina Mired of Jordan will be the first Arab president of the Union for International Cancer Control.
by Sue Rochman
The sugar-feeds-cancer myth, talking to a friend with cancer, and facing down "scanxiety."
An outdoor adventure camp benefits cancer survivors of all ages.
by Lindsey Konkel
Morgan Bolt, Esther Brandon, Randy Lopez.
Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.
by Kate Yandell
COVID-19 slowed or stopped enrollment in some cancer clinical trials.
Data shed light on risk factors for death among people with cancer infected with the coronavirus.
I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.
by Adam Hayden
Identifying patients whose cancers will have durable responses to checkpoint inhibitors can guide treatment.
The FDA has expanded the use of the PARP-targeted therapeutic olaparib to include the treatment of certain patients with metastatic prostate cancer.
Bladder cancer is the sixth most prevalent cancer in the United States and has a high rate of recurrence.
Handle With Care
donate to the AACR